aap bio implants group and partners are granted EUR 1 million in funding to develop and manufacture ultra-clean biopolymers

The aap bio implants group, comprising the aap Implantate AG Group companies that are involved in medical biomaterials, has been able with cooperation partners to secure EUR 1 million in development funding from the European Union’s Euro-Transbio program.

The aap bio implants group plans to use this funding to set up GMP production (Good Manufacturing Practice) of ultra-clean, detoxicated biopolymers at its Dutch location in Nijmegen. These biopolymers are used, inter alia, in the fast-growing field of adhesion barriers in spine operations and internal surgery to prevent organic tissue from adhering. This is a product area in which aap bio implants is already active.

The new, patented production process - considered highly innovative and commercially promising by grant application evaluators - will enable aap bio implants to meet its own fast-growing requirements in the years ahead at a significantly lower cost than by using existing processes and also to supply third parties on a large scale.